| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 64, 767-771, Copyright © 1996 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
Y Hata, M Yamamoto, M Ohni, K Nakajima, Y Nakamura and T Takano
Department of Medicine and Gerontology, Kyorin University School of Medicine, Tokyo, Japan.
A placebo-controlled study was conducted to test the effect of Calpis (Calpis Food Industry Co, Ltd, Tokyo, Japan) sour milk, i.e., a milk fermented with a starter containing Lactobacillus helveticus and Saccharomyces cerevisiae, on the blood pressure of 30 elderly hypertensive patients, most of whom were taking antihypertensive medication. Subjects were randomly assigned to two groups. One group ingested daily 95 mL of the sour milk for 8 wk, and the other group ingested the same amount of artificially acidified milk as a placebo for 8 wk. In the sour-milk group, systolic blood pressure decreased significantly 4 and 8 wk after ingestion, by 9.4 +/- 3.6 mm Hg (mean+/- SE, P < 0.05) and 14.1 +/- 3.1 mm Hg (P < 0.01), respectively. The diastolic blood pressure also decreased significantly, by 6.9 +/- 2.2 mm Hg (P < 0.01), by 8 wk after ingestion of the sour milk began. No significant changes in blood pressure were observed in the placebo group. The decrease in systolic and diastolic blood pressure in the sour-milk group tended to be greater than in the placebo group. No marked changes were observed in other indexes, including pulse rate, body weight, and blood serum variables in both groups.
This article has been cited by other articles:
|
|
 |
|
  C. Weimann, H. Meisel, and G. Erhardt Short communication: Bovine {kappa}-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides J Dairy Sci, May 1, 2009; 92(5): 1885 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meyer, U. Butikofer, B. Walther, D. Wechsler, and R. Sieber Hot topic: Changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties J Dairy Sci, March 1, 2009; 92(3): 826 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. van Mierlo, M. M. Koning, K. van der Zander, and R. Draijer Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies Am. J. Clinical Nutrition, February 1, 2009; 89(2): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Kris-Etherton, J. A. Grieger, K. F. Hilpert, and S. G. West Milk Products, Dietary Patterns and Blood Pressure Management J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 103S - 119S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. van der Zander, M. L Bots, A. A. Bak, M. M. Koning, and P. W de Leeuw Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1697 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Hebert, G. Mamone, G. Picariello, R. R. Raya, G. Savoy, P. Ferranti, and F. Addeo Characterization of the Pattern of {alpha}s1- and {beta}-Casein Breakdown and Release of a Bioactive Peptide by a Cell Envelope Proteinase from Lactobacillus delbrueckii subsp. lactis CRL 581 Appl. Envir. Microbiol., June 15, 2008; 74(12): 3682 - 3689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Engberink, E. G. Schouten, F. J. Kok, L. A.J. van Mierlo, I. A. Brouwer, and J. M. Geleijnse Lactotripeptides Show No Effect on Human Blood Pressure: Results From a Double-Blind Randomized Controlled Trial Hypertension, February 1, 2008; 51(2): 399 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Butikofer, J. Meyer, R. Sieber, B. Walther, and D. Wechsler Occurrence of the Angiotensin-Converting Enzyme-Inhibiting Tripeptides Val-Pro-Pro and Ile-Pro-Pro in Different Cheese Varieties of Swiss Origin J Dairy Sci, January 1, 2008; 91(1): 29 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Foltz, E. E. Meynen, V. Bianco, C. van Platerink, T. M. M. G. Koning, and J. Kloek Angiotensin Converting Enzyme Inhibitory Peptides from a Lactotripeptide-Enriched Milk Beverage Are Absorbed Intact into the Circulation J. Nutr., April 1, 2007; 137(4): 953 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jauhiainen and R. Korpela Milk Peptides and Blood Pressure J. Nutr., March 1, 2007; 137(3): 825S - 829S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quiros, M. Ramos, B. Muguerza, M. A. Delgado, P. J. Martin-Alvarez, A. Aleixandre, and I. Recio Determination of the Antihypertensive Peptide LHLPLP in Fermented Milk by High-Performance Liquid Chromatography-Mass Spectrometry J Dairy Sci, December 1, 2006; 89(12): 4527 - 4535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Geerlings, I. C. Villar, F. H. Zarco, M. Sanchez, R. Vera, A. Z. Gomez, J. Boza, and J. Duarte Identification and characterization of novel Angiotensin-converting enzyme inhibitors obtained from goat milk. J Dairy Sci, September 1, 2006; 89(9): 3326 - 3335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miguel, I. Recio, M. Ramos, M. A. Delgado, and M. A. Aleixandre Antihypertensive Effect of Peptides Obtained from Enterococcus faecalis-Fermented Milk in Rats. J Dairy Sci, September 1, 2006; 89(9): 3352 - 3359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Aihara, O. Kajimoto, H. Hirata, R. Takahashi, and Y. Nakamura Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension J. Am. Coll. Nutr., August 1, 2005; 24(4): 257 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Bernard, Y. Nakamura, I. Bando, and J. H. Mennear Studies of the Toxicological Potential of Tripeptides (L-Valyl-L-prolyl-L-proline and L-Isoleucyl-L-prolyl-L-proline): II. Introduction International Journal of Toxicology, July 1, 2005; 24(4_suppl): 5 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Walsh, H. Bernard, B. A. Murray, J. MacDonald, A.-K. Pentzien, G. A. Wright, J.-M. Wal, A. D. Struthers, H. Meisel, and R. J. FitzGerald In Vitro Generation and Stability of the Lactokinin {beta}-Lactoglobulin Fragment (142-148) J Dairy Sci, November 1, 2004; 87(11): 3845 - 3857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mizuno, S. Nishimura, K. Matsuura, T. Gotou, and N. Yamamoto Release of Short and Proline-Rich Antihypertensive Peptides from Casein Hydrolysate with an Aspergillus oryzae Protease J Dairy Sci, October 1, 2004; 87(10): 3183 - 3188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murakami, H. Tonouchi, R. Takahashi, H. Kitazawa, Y. Kawai, H. Negishi, and T. Saito Structural Analysis of a New Anti-Hypertensive Peptide ({beta}-Lactosin B) Isolated from a Commercial Whey Product J Dairy Sci, July 1, 2004; 87(7): 1967 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. FitzGerald, B. A. Murray, and D. J. Walsh Hypotensive Peptides from Milk Proteins J. Nutr., April 1, 2004; 134(4): 980S - 988S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Seppo, T. Jauhiainen, T. Poussa, and R. Korpela A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects Am. J. Clinical Nutrition, February 1, 2003; 77(2): 326 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vermeirssen, J. Van Camp, K. Decroos, L. Van Wijmelbeke, and W. Verstraete The Impact of Fermentation and In Vitro Digestion on the Formation of Angiotensin-I-Converting Enzyme Inhibitory Activity from Pea and Whey Protein J Dairy Sci, February 1, 2003; 86(2): 429 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stanton, G. Gardiner, H. Meehan, K. Collins, G. Fitzgerald, P B. Lynch, and R P. Ross Market potential for probiotics Am. J. Clinical Nutrition, February 1, 2001; 73(2): 476S - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bos, C. Gaudichon, and D. Tome Nutritional and Physiological Criteria in the Assessment of Milk Protein Quality for Humans J. Am. Coll. Nutr., April 1, 2000; 19(90002): 191S - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Sanders Considerations for Use of Probiotic Bacteria to Modulate Human Health J. Nutr., February 1, 2000; 130(2): 384 - 384. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
